Yes, impurities in Lurasidone can affect its bioavailability by altering its pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion. Their control ensures consistent drug performance.

Ongoing research aims to develop more efficient analytical methods and manufacturing processes to minimize impurities in Lurasidone, ensuring it meets the highest quality and safety standards.

Manufacturers implement robust in-process controls and perform regular testing and monitoring of raw materials, intermediates, and final products to ensure impurity levels in Lurasidone are within acceptable limits.

Lurasidone impurities should be stored, at a controlled room temperature, usually between 2-8 °C.